LAM
ABBV icon

Lummis Asset Management’s AbbVie ABBV Stock Holding History

Lummis Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Hold
6,229
– – 0.96% 29
2026
Q1 		$1.32M Hold
6,229
– – 0.79% 34
2025
Q4 		$1.42M Hold
6,229
– – 0.88% 29
2025
Q3 		$1.44M Hold
6,229
– – 0.95% 29
2025
Q2 		$1.23M Hold
6,229
– – 0.81% 30
2025
Q1 		$1.22M Buy
6,229
+6,209
+31,045% +$1.21M 0.84% 32
2024
Q4 		$3.55K Hold
20
– – ﹤0.01% 116
2024
Q3 		$3.95K Hold
20
– – ﹤0.01% 116
2024
Q2 		$3.43K Hold
20
– – ﹤0.01% 119
2024
Q1 		$3.64K Sell
20
-6,209
-100% -$1.07M ﹤0.01% 123
2023
Q4 		$965K Buy
+6,229
New +$908K 0.74% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lummis Asset Management's ABBV Position: Q2 2026 in Review

Lummis Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 6,229 shares worth $1.6M. The position accounts for 0.96% of the portfolio, ranked #29.

Lummis Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lummis Asset Management held 6,229 shares of AbbVie worth $1.6M as of Q2 2026.
  • Lummis Asset Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.96% of Lummis Asset Management's portfolio in Q2 2026, its #29 holding.
  • Lummis Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lummis Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.